ATYPICAL DUCTAL BREAST HYPERPLASIA

Clinical trials for ATYPICAL DUCTAL BREAST HYPERPLASIA explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL DUCTAL BREAST HYPERPLASIA trials appear

Sign up with your email to follow new studies for ATYPICAL DUCTAL BREAST HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Diabetes drug metformin tested as breast cancer shield

Prevention Ongoing

This study tests whether metformin, a common diabetes drug, can prevent breast cancer in women at high risk. Participants take metformin or a placebo for 12 months. Researchers check breast tissue samples for abnormal cells to see if the drug reduces cancer risk.

Matched conditions: ATYPICAL DUCTAL BREAST HYPERPLASIA

Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention

Last updated May 01, 2026 16:00 UTC

ATYPICAL DUCTAL BREAST HYPERPLASIA

Get alerted when new ATYPICAL DUCTAL BREAST HYPERPLASIA trials appear

Diabetes drug metformin tested as breast cancer shield